Navigation Links
Cold treatment opens doors for citrus exports to Japan
Date:11/29/2007

Citrus growers in eastern Australia now have greater access to the Japanese market as a result of research by the NSW Department of Primary Industries (DPI).

Trials undertaken at NSW DPIs Gosford Horticultural Institute have proven that cold storage at temperatures of 2 or 3C can effectively kill Queensland Fruit Fly in citrus stored for 14 to16 days.

Cold treatment at these temperatures provides greater market flexibility and reduces problems associated with cold chilling such as internal fruit and skin damage.

This new cold treatment is the Australian citrus industrys preferred method and Japan formally accepted it after the Federal Government advised them of the results of extensive replicated trials conducted at Gosford and in Western Australia.

At Gosford, post-harvest researchers lead by NSW DPIs Andrew Jessup examined the effect of the cold treatment on QFF on citrus sourced from the Murrumbidgee Irrigation Area (MIA), Victorias Sunraysia and South Australias Riverland regions.

In WA, researchers from the WA Department of Agriculture examined the impact of the same treatment on the Mediterranean Fruit Fly (MFF) in local citrus.

(QFF is endemic to the east coast of Australia, extending inland for 600 kilometres or more, while MFF is found in pockets around major townships in WA.)

Mr Jessup says the QFF, Bactrocera tryoni, is more suited to tropical and subtropical conditions and is more susceptible to cold treatment than the MFF.

The trials show that QFF were killed after 14-16 days storage, compared with 16 to 20 days for MFF.

The previous cold treatment at 1 C, if not managed correctly can cause chilling injury to fruit.

Mr Jessup said that the new higher temperatures for dis-infestation help to conserve fruit quality and are easier to maintain in-transit.

They also provide an alternative to methyl bromide fumigation, which is toxic to citrus and shortens its shelf life. Methyl bromide is also being phased out in Australia because it is ozone depleting, he said.

The research is expected to assist in gaining market access for Australian citrus to other countries in the northern hemisphere.


'/>"/>

Contact: Andrew Jessup
andrew.jessup@dpi.nsw.gov.au
61-243-481-965
New South Wales Department of Primary Industries
Source:Eurekalert

Related biology news :

1. Nicotinic receptors may be important targets for treatment of multiple addictions
2. A new radiation therapy treatment developed for head and neck cancer patients
3. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
4. Presence of gene mutation helps guide thyroid cancer treatment
5. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
6. New genetic research into nicotine addiction shows promise for personalized treatment
7. Interleukin-8, key marker for colorectal cancer treatment
8. New class of drug offers hope to treatment-resistant AIDS patients
9. Paradigm shift in Alzheimerss research: new treatments
10. New research on structure of bones raises questions for treatment of osteoporosis
11. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology: